v3.25.2
Net Income (Loss) Per Share (Tables)
 6 Months Ended
Jun. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic and Diluted Net Income (Loss) Per Share
A reconciliation of the numerator and denominator used in the calculation of basic and diluted net loss per share of Class A common stock is as follows:
Three months ended Jun. 30,Six months ended Jun. 30,
(in thousands, except per share amounts)2025202420252024
Numerator:
Net loss
$(115,989)$(59,314)$(125,775)$(80,660)
Less: Net loss attributable to non-controlling interests
(61,712)(33,318)(67,090)(45,448)
Net loss attributable to GoHealth, Inc.
(54,277)(25,996)(58,685)(35,212)
Less: Dividends accumulated on redeemable convertible preferred stock972 907 1,928 1,799 
Net loss attributable to common stockholders - basic and diluted
(55,249)(26,903)(60,613)(37,011)
Denominator:
Weighted-average shares of Class A common stock outstanding—basic and diluted
10,830 9,973 10,603 9,844 
Net loss per share of Class A common stock—basic and dilutive
$(5.10)$(2.70)$(5.72)$(3.76)
Schedule of Antidilutive Securities Excluded From Calculation of Diluted Income (Loss) Per Share
The following number of shares were excluded from the calculation of diluted loss per share of Class A common stock because the effect of including such potentially dilutive shares would have been antidilutive:
Jun. 30,
(in thousands)20252024
Equity awards
3,308 2,630 
Redeemable convertible preferred stock
4,113 3,989 
Class B common stock12,623 12,780